A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Name: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)
Published: 2010
License: Public Domain

Genzyme, a Sanofi Company · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

beta genz

gaucher disease, genz-112638, beta-glucosidase, acid β-glucosidase, glucocerebrosidase, glucosylceramide, d-glucosyl-n-acylsphingosine glucohydrolase, substrate reduction therapy, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Related documents